The U.S. Department of Health has announced a $500 million cut to funding for mRNA vaccine research — sending shock waves through the global scientific community. The mRNA vaccine technology has long been considered the next best step for treating various cancers and other diseases, and was pivotal in curbing the COVID-10 pandemic. But how does this decision affect research around the globe? UBC professor of biochemistry and Order of Canada recipient Pieter Cullis joins host Janella Hamilton in conversation to explain.
